Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DALIRESP
- Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy
- A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PIL
- Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma
- Roflumilast or Azithromycin to Prevent COPD Exacerbations (RELIANCE)
- Trial of Roflumilast in Asthma Management (TRIM)
- Study of Roflumilast in Combination With Standard Chemotherapy for High-risk Diffuse Large B-cell Lymphoma
- The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis
- The Role of Phosphodiesterase Inhibitors in Incretin Secretion
- Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD
- Effects of Roflumilast in Hospitalized Chronic Obstructive Pulmonary Disease( COPD) on Mortality and Re-hospitalization
- Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)
- Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)
- Roflumilast Plus Montelukast in Adults With Severe Asthma
- Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD
- A Placebo-controlled Trial of Daliresp on Chronic Obstructive Pulmonary Disease (COPD)
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
- Roflumilast and Cognition
Clinical trials list
click for details